Dr. felix chan

Dr. Felix Chan is Assistant Professor in Pharmacology at the University of Birmingham. His main research interest is in metabolism in epilepsy. Felix did his undergraduate in medical sciences at Universitas Indonesia in Jakarta, Indonesia, from 2008 to 2011.

​

He then moved to Newcastle University to do an M.Res in Neuroscience. This continued as a PhD in Neuroscience from 2012 to 2018, where Felix developed the first-ever in vitro brain slice model of mitochondrial epilepsy, characterising the importance of glutamine metabolism in this type of epilepsy. Felix then moved to Brown University to do a postdoctoral training, working on paediatric focal epilepsy like tuberous sclerosis complex (TSC) and focal cortical dysplasia (FCD).

​

His work on TSC was awarded with many accolades, including a prestigious NIH DSC-TSC Alliance Young Investigator Fellowship award and the American Epilepsy Society Young Investigator Award in 2020. Felix moved to Aston in September 2022 to establish his research group; Chan Lab (https://www.chanlab.co.uk/), continuing to look at lysine metabolism in TSC. Felix works closely with many patient charity groups in the UK, including the UK Rare Epilepsy Together network (UKRET) and currently also serves as a member of the scientific advisory board for CureDHDDS.

​

Felix continues to be fascinated by the investigation of the energetics of the brain and particularly how we can leverage our understanding of brain metabolism to develop new treatments for epilepsy.